IEQ Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.1M Sell
32,151
-3,819
-11% -$718K 0.03% 452
2026
Q1
$7.09M Buy
35,970
+775
+2% +$149K 0.03% 426
2025
Q4
$6.47M Sell
35,195
-2,170
-6% -$381K 0.02% 460
2025
Q3
$5.73M Buy
37,365
+13,578
+57% +$2.06M 0.02% 456
2025
Q2
$3.32M Buy
23,787
+3,458
+17% +$485K 0.02% 529
2025
Q1
$2.99M Buy
20,329
+809
+4% +$117K 0.02% 485
2024
Q4
$2.56M Sell
19,520
-670
-3% -$93.8K 0.02% 440
2024
Q3
$3.15M Buy
20,190
+1,557
+8% +$251K 0.04% 281
2024
Q2
$2.91M Buy
18,633
+4,530
+32% +$682K 0.04% 264
2024
Q1
$1.91M Buy
14,103
+248
+2% +$32.8K 0.03% 329
2023
Q4
$1.87M Sell
13,855
-1,287
-8% -$167K 0.03% 303
2023
Q3
$2.05M Buy
15,142
+344
+2% +$47K 0.04% 261
2023
Q2
$2.12M Buy
14,798
+2,509
+20% +$369K 0.04% 262
2023
Q1
$1.71M Sell
12,289
-331
-3% -$44.5K 0.04% 281
2022
Q4
$1.71M Sell
12,620
-1,232
-9% -$155K 0.05% 269
2022
Q3
$1.52M Buy
13,852
+1,088
+9% +$138K 0.04% 274
2022
Q2
$1.69M Buy
12,764
+940
+8% +$123K 0.05% 225
2022
Q1
$1.57M Buy
11,824
+2,112
+22% +$253K 0.04% 249
2021
Q4
$1.13M Sell
9,712
-1,098
-10% -$129K 0.03% 283
2021
Q3
$1.3M Buy
+10,810
New +$1.26M 0.03% 246
2020
Q1
Sell
-2,146
Closed -$214K 379
2019
Q4
$214K Buy
+2,146
New +$202K 0.02% 375

Other funds holding AZN

IEQ Capital's AZN Position: Q2 2026 in Review

IEQ Capital reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $718K and leaving 32,151 shares worth $6.1M. The position accounts for 0.03% of the portfolio, ranked #452.

IEQ Capital first reported a position in AZN in Q4 2019 and has held it in 21 quarters since. The position peaked at $7.09M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • IEQ Capital held 32,151 shares of AstraZeneca worth $6.1M as of Q2 2026.
  • IEQ Capital sold 3,819 AstraZeneca shares in Q2 2026, an estimated $718K.
  • AstraZeneca made up 0.03% of IEQ Capital's portfolio in Q2 2026, its #452 holding.
  • IEQ Capital first reported a position in AstraZeneca in Q4 2019 and has held it in 21 quarters since.
  • IEQ Capital's AstraZeneca position peaked at $7.09M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.